Phase 1 Clinical Trial Design -- 2

@Zawiya3

With my vast repertoire of skills and experience in the clinical research field, I bring forth a unique blend of compliance and data management. I have an unwavering commitment to adhering to global ICH-GCP standards, which will be instrumental in ensuring your Phase 1 clinical trial design is meticulous and meets all regulatory requirements. Having been involved in early-phase trials, I am well-versed with the rigors that come with such studies and hold a comprehensive understanding of pharmacovigilance and EDC configuration. Additionally, my proficiency in statistical analysis tools like SPSS Statistics, SAS and R will help me craft a precise statistical analysis plan focused on descriptive safety endpoints. This, combined with my bone-deep respect for safety protocols and an understanding of 21 CFR Part 11, guarantees meticulous and real-time safety monitoring. While timelines will be flexible to prioritize scientific rigour, my expertise as a professional solution architect allows me to work efficiently and maintain quality. I've previously worked on multiple medical projects including health-interfaces with AWS architecture, showcasing my ability to merge cutting-edge technology with healthcare domain knowledge. Together, we can ensure your study edge past regulatory scrutiny while optimizing scientific insights gleaned from collected data!

@realroshan102

Hi, I understand the critical importance of rigorous safety oversight in your first-in-human Phase 1 clinical trial. With my extensive experience in early-phase trial design, pharmacovigilance, and EDC configuration, I will transform your pre-clinical and CMC data into a comprehensive study dossier fully compliant with ICH-GCP and 21 CFR Part 11. This includes a robust dose-escalation protocol with stopping rules, DSMB charter, safety monitoring plan, and all essential documentation such as informed consent forms and CRFs developed in REDCap or Medidata Rave. I also offer expertise in creating detailed statistical analysis plans in SAS or R and handling ethics and regulatory submission packages, ensuring a smooth approval process. My past projects include redacted protocols and CSR excerpts from similar first-in-human trials, which demonstrate my capability to meet your high standards. I propose to start immediately, prioritizing compliance and scientific rigor. Which EDC platform do you currently prefer for the CRFs and data capture workflow? Best regards, Roshan

@DrRevathiV25

I am a Medical Doctor with strong clinical experience, hands-on involvement in clinical trials, and a Master’s in Digital Health, enabling high-quality, regulator-ready clinical documentation. I have supported first-in-human and early Phase 1 clinical trials with a strong focus on safety, tolerability, and full compliance with ICH-GCP and FDA requirements. I can translate your pre-clinical and CMC package into a complete, inspection-ready Phase 1 study dossier, prioritizing rigorous safety oversight, clear dose-escalation logic, and clean, auditable documentation. I will deliver: • Phase 1 dose-escalation protocol with predefined stopping rules, DSMB charter, and real-time safety monitoring • Informed Consent Form, Investigator’s Brochure, pharmacy manual, and compliant CRFs • EDC build and validation in REDCap, Medidata Rave, or equivalent (21 CFR Part 11 compliant) • Statistical analysis plan focused on descriptive safety and tolerability endpoints (SAS or R) • Ethics and regulatory submission packages with draft cover letters and response templates • ICH E3-aligned CSR outline ready for final data population I have experience across early-phase development, pharmacovigilance workflows, and EDC configuration, and I’m familiar with internal QA expectations under ICH E6(R2). Redacted protocol sections and CSR excerpts can be shared upon request. If you’re looking for scientifically rigorous, regulator-ready Phase 1 support, I’d be glad to discuss next steps.

@volodymyrkoval

Hi, I am excited to bring my expertise in clinical trial design to your first-in-human Phase 1 clinical trial. With over 10 years of experience in early-phase trials and a strong background in pharmacovigilance, I am well-prepared to convert your pre-clinical package and CMC data into a comprehensive study dossier. I will ensure that all deliverables align with ICH-GCP standards, focusing on safety and regulatory compliance. My experience includes successful projects where I crafted protocols, informed consent forms, and statistical analysis plans using SAS and EDC systems. I understand the importance of rigorous oversight, and I am committed to delivering quality work that meets your timelines and standards. Best regards, Volodymyr

@akxsa

Hello, I am a Pharm-D–qualified healthcare professional with training in clinical research and ICH-GCP (E6) principles, interested in supporting your first-in-human Phase 1 study with a strong focus on safety and compliance. I can assist in preparing study documents including protocol components, safety monitoring plans, informed consent forms, IB content support, pharmacy manuals, and CRFs aligned with ICH E6(R2) and 21 CFR Part 11. I am familiar with early-phase trial objectives, descriptive safety endpoints, DSMB oversight concepts, and CSR structure per ICH E3. I work carefully, prioritize data integrity, and welcome internal QA review to ensure audit-ready documentation. Redacted samples can be shared if required. I would be glad to discuss how I can support your study start-up and documentation needs. Best regards, Aqsa Ahmed

@mostafar56

As a medical doctor and seasoned clinical researcher, I offer comprehensive expertise in managing Phase 1 trials from pre-clinical synthesis to final CSR. I specialize in drafting ICH-GCP compliant protocols with rigorous safety monitoring and dose-escalation rules. I am highly proficient in using SPSS for advanced statistical analysis, specifically tailored for safety endpoints and descriptive data required in FIH studies. My background ensures that every deliverable—from DSMB charters to 21 CFR Part 11 compliant CRFs—meets the highest scientific and regulatory standards. I prioritize clear, direct communication to address any clinical complexities immediately, ensuring your study’s integrity is never compromised.